Pura Vida Investments, LLC Athira Pharma, Inc. Transaction History

Pura Vida Investments, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$2.76 - $3.71 $171,738 - $230,851	-62,224 Reduced 44.47%	77,700 $246,000
Q3 2022 Nov 14, 2022	SELL	$2.93 - $3.96 $375,646 - $507,699	-128,207 Reduced 47.82%	139,924 $416,000
Q2 2022 Aug 15, 2022	SELL	$2.74 - $13.43 $195,463 - $958,055	-71,337 Reduced 21.01%	268,131 $818,000
Q1 2022 May 16, 2022	SELL	$8.96 - $13.51 $1.21 Million - $1.82 Million	-134,835 Reduced 28.43%	339,468 $4.58 Million
Q4 2021 Feb 14, 2022	BUY	$9.17 - $16.39 $4.35 Million - $7.77 Million	474,303 New	474,303 $6.18 Million

16.9M

112K

68K

Ticker ATHA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,817,700
Market Cap $24.2M
Description
Athira Pharma, Inc., a late clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation. The company's lead product candidate is ATH-1017, a blood brain barrier-penetrating, small molecule HGF/MET positive modulator that is in LIFT-AD Phase 3 and ACT-AD Phase 2 clinical tri...

Get notified when there are updates to the investment portfolio of Pura Vida Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Pura Vida Investments, LLC with notifications on news.